Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC9A1 | P19634 | 9/20 | 0.55 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.55 |
| ▸ | HCAR3 | P49019 | 1/20 | 0.51 |
| ▸ | CYP4Z1 | Q86W10 | 2/20 | 0.50 |
| ▸ | ATM | Q13315 | 2/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
| ▸ | THPO | P40225 | 1/20 | 0.50 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.46 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.43 |
| ▸ | PTPRC | P08575 | 1/20 | 0.43 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | KCNMA1 | Q12791 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10607208 | 0.84 | SLC9A1 (0.52) | SLC9A1KEAP1CYP4Z1ATMPOLB | |
| SCHEMBL13351503 | 0.81 | SLC9A1 (0.48) | SLC9A1KEAP1CYP4Z1ATMPOLB | |
| SCHEMBL15444316 | 0.81 | SLC9A1 (0.53) | SLC9A1KEAP1CYP4Z1ATMPOLB | |
| SCHEMBL13248923 | 0.81 | SLC9A1 (0.48) | SLC9A1KEAP1CYP4Z1ATMPOLB | |
| SCHEMBL21220894 | 0.80 | SLC9A1 (0.52) | SLC9A1KEAP1CYP4Z1ATMPOLB | |
| SCHEMBL10954907 | 0.80 | SLC9A1 (0.47) | SLC9A1KEAP1CYP4Z1ATMPOLB | |
| SCHEMBL15426054 | 0.80 | SLC9A1 (0.47) | SLC9A1KEAP1CYP4Z1ATMPOLB | |
| SCHEMBL5217736 | 0.80 | SLC9A1 (0.47) | SLC9A1KEAP1HCAR3CYP4Z1ATM | |
| SCHEMBL13604172 | 0.80 | GAA (0.50) | SLC9A1KEAP1HCAR3ATMPOLB | |
| SCHEMBL5437514 | 0.79 | SLC9A1 (0.50) | SLC9A1KEAP1CYP4Z1ATMPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 112 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12264217-B2 | Surface treatment film, manufacturing method therefor, and article | DAINICHISEIKA COLOR & CHEMICALS MFG. CO., LTD. (JP) | 2025-04-01 | — | — | US | disclosed |
| US-12037324-B2 | Biarylmethyl heterocycles | BRISTOL-MYERS SQUIBB COMPANY (US) | 2024-07-16 | — | — | US | disclosed |
| US-12037324-B2 | Biarylmethyl heterocycles | BRISTOL-MYERS SQUIBB COMPANY (US) | 2024-07-16 | — | — | US | disclosed |
| US-20230348654-A1 | SURFACE TREATMENT FILM, MANUFACTURING METHOD THEREFOR, AND ARTICLE | DAINICHISEIKA COLOR & CHEMICALS MFG. CO., LTD. (JP) | 2023-11-02 | — | — | US | disclosed |
| US-11788080-B2 | Modified cleavases, uses thereof and related kits | Encodia, Inc. (US) | 2023-10-17 | — | — | US | disclosed |
| US-11788080-B2 | Modified cleavases, uses thereof and related kits | Encodia, Inc. (US) | 2023-10-17 | — | — | US | disclosed |
| US-11780963-B2 | Multi-arm multi-claw polyethylene glycol derivative suitable for click chemistry reactions | JENKEM TECHNOLOGY CO., LTD. (TIANJIN) (CN) | 2023-10-10 | — | — | US | disclosed |
| US-11782062-B2 | Kits for analysis using nucleic acid encoding and/or label | Encodia, Inc. (US) | 2023-10-10 | — | — | US | disclosed |
| US-11782062-B2 | Kits for analysis using nucleic acid encoding and/or label | Encodia, Inc. (US) | 2023-10-10 | — | — | US | disclosed |
| US-11780963-B2 | Multi-arm multi-claw polyethylene glycol derivative suitable for click chemistry reactions | JENKEM TECHNOLOGY CO., LTD. (TIANJIN) (CN) | 2023-10-10 | — | — | US | disclosed |
| US-20100105693-A1 | Modulators of Muscarinic Receptors | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2010-04-29 | — | — | US | disclosed |
| US-7605160-B2 | Pyrrolotriazine kinase inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2009-10-20 | — | — | US | disclosed |
| US-20090186927-A1 | TRANS-9,10-DEHYDROEPOTHILONE C AND D, ANALOGS THEREOF AND METHODS OF MAKING THE SAME | KOSAN BIOSCIENCES, INC. (US) | 2009-07-23 | — | — | US | disclosed |
| US-20090186927-A1 | TRANS-9,10-DEHYDROEPOTHILONE C AND D, ANALOGS THEREOF AND METHODS OF MAKING THE SAME | KOSAN BIOSCIENCES, INC. (US) | 2009-07-23 | — | — | US | disclosed |
| US-20090186869-A1 | Antiviral compounds | GILEAD SCIENCES, INC. (US) | 2009-07-23 | — | — | US | disclosed |
| US-20090186869-A1 | Antiviral compounds | GILEAD SCIENCES, INC. (US) | 2009-07-23 | — | — | US | disclosed |
| US-20080300240-A1 | PDE10 INHIBITORS AND RELATED COMPOSITIONS AND METHODS | OMEROS CORPORATION (US) | 2008-12-04 | — | — | US | disclosed |
| US-20080058337-A1 | PYRROLOTRIAZINE KINASE INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY | 2008-03-06 | — | — | US | disclosed |
| EP-0258021-B1 | METHOD OF INHIBITING THE CORROSION OF COPPER IN AQUEOUS SYSTEMS | BETZ EUROPE, INC. (US) | 1989-10-18 | — | — | EP | disclosed |
| EP-0258021-A1 | Method of inhibiting the corrosion of copper in aqueous systems | BETZ EUROPE, INC. (US) | 1988-03-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080300240-A1 | PDE10 INHIBITORS AND RELATED COMPOSITIONS AND METHODS | PDE10A, PDE9A, PDE7A | SLC9A1 3025/4885KEAP1 4663/4885HCAR3 2411/4885 |
| US-20100105693-A1 | Modulators of Muscarinic Receptors | CHRM3, CHRM5, CHRM2 | SLC9A1 3778/4885KEAP1 2211/4885HCAR3 66/4885 |
| US-20090186927-A1 | TRANS-9,10-DEHYDROEPOTHILONE C AND D, ANALOGS THEREOF AND METHODS OF MAKING THE SAME | TMSB10, TUBA1C, TUBB1 | SLC9A1 3294/4885KEAP1 164/4885HCAR3 4509/4885 |
| US-20090186869-A1 | Antiviral compounds | MAVS, EIF2AK2, ZC3HAV1 | SLC9A1 4671/4885KEAP1 2326/4885HCAR3 4118/4885 |
| US-11780963-B2 | Multi-arm multi-claw polyethylene glycol derivative suitable for click chemistry reactions | LIG1, ALK, LIG3 | SLC9A1 4858/4885KEAP1 1727/4885HCAR3 1681/4885 |
| US-12037324-B2 | Biarylmethyl heterocycles | ARRB1, ADRB2, ADRB1 | SLC9A1 4110/4885KEAP1 603/4885HCAR3 232/4885 |
| US-20080058337-A1 | PYRROLOTRIAZINE KINASE INHIBITORS | NTRK2, NTRK1, NTRK3 | SLC9A1 4628/4885KEAP1 2763/4885HCAR3 975/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.